Company logo

SGRY - Surgery Partners, Inc.

NASDAQ -> Healthcare -> Medical Care Facilities
Brentwood, United States
Type: Equity

SGRY price evolution
SGRY
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $195.9 $236 $177.4 $245.5
Short term investments
Net receivables $496.4 $462.8 $449.9 $452.9
Inventory $75.2 $69.4 $70.3 $71.8
Total current assets $895 $876.2 $810.2 $868.9
Long term investments $184.1 $196.3 $192.2 $191.6
Property, plant & equipment $1224 $1184.2 $1093.2 $1118.3
Goodwill & intangible assets $4380.8 $4301 $4291.2 $4252.6
Total noncurrent assets $5981.7 $5903.9 $5810.4 $5774.4
Total investments $184.1 $196.3 $192.2 $191.6
Total assets $6876.7 $6780.1 $6620.6 $6643.3
Current liabilities
Accounts payable $171.8 $148.8 $131.5 $144.4
Deferred revenue
Short long term debt $73.3 $62.1 $64.7 $62.9
Total current liabilities $523 $501.4 $458.6 $475.1
Long term debt $2950.7 $2881.1 $2768.9 $2799.7
Total noncurrent liabilities $3319.2 $3292.2 $3179.2 $3225.7
Total debt $3024 $2943.2 $2833.6 $2862.6
Total liabilities $3842.2 $3793.6 $3637.8 $3700.8
Shareholders' equity
Retained earnings -$569.2 -$568.2 -$563.3 -$582.3
Other shareholder equity $57.5 $77 $78.8 $64.9
Total shareholder equity $1987.2 $2004.6 $2018.2 $1962
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $195.9 $282.9 $389.9 $317.9
Short term investments
Net receivables $496.4 $456.3 $430.2 $382.2
Inventory $75.2 $71.4 $61.1 $56.4
Total current assets $895 $921 $946.1 $801.5
Long term investments $184.1 $190.3 $88.7 $90.3
Property, plant & equipment $1224 $1155.7 $953.8 $854.7
Goodwill & intangible assets $4380.8 $4179.4 $3955.5 $3514.9
Total noncurrent assets $5981.7 $5761.1 $5171.5 $4611.7
Total investments $184.1 $190.3 $88.7 $90.3
Total assets $6876.7 $6682.1 $6117.6 $5413.2
Current liabilities
Accounts payable $171.8 $151.6 $124.9 $100.2
Deferred revenue $3.2 $64.4 $109.8
Short long term debt $73.3 $62.8 $60.4 $64.4
Total current liabilities $523 $493.4 $536.8 $556.8
Long term debt $2950.7 $2559 $3194 $3093.3
Total noncurrent liabilities $3319.2 $3247.8 $3611.2 $3974.3
Total debt $3024 $2893.2 $3254.4 $3157.7
Total liabilities $3842.2 $4683.9 $4148 $4531.1
Shareholders' equity
Retained earnings -$569.2 -$557.3 -$502.7 -$431.8
Other shareholder equity $57.5 $76.2 -$31.5 -$61
Total shareholder equity $1987.2 $1998.2 $1089 $115.6
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $735.4 $674.1 $667.6 $666.2
Cost of revenue $541.8 $508.3 $513.5 $532.2
Gross Profit $193.6 $165.8 $154.1 $134
Operating activities
Research & development
Selling, general & administrative $20.9 $36.8 $31.2 $32
Total operating expenses $81.5 $86.7 $59.1 $90.9
Operating income $112.1 $79.1 $95 $43.1
Income from continuing operations
EBIT $53.7 $48 $58.8 $20.3
Income tax expense $6 $3.1 -$7.8 -$1.6
Interest expense $48.7 $49.8 $47.7 $46.8
Net income
Net income -$1 -$4.9 $18.9 -$24.9
Income (for common shares) -$1 -$4.9 $18.9 -$24.9
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $2743.3 $2539.3 $2225.1 $1860.1
Cost of revenue $2095.8 $1964.4 $1733.7 $1480.3
Gross Profit $647.5 $574.9 $491.4 $379.8
Operating activities
Research & development
Selling, general & administrative $120.9 $102.2 $104 $97.1
Total operating expenses $318.2 $227.3 $191.4 $207.6
Operating income $329.3 $347.6 $300 $172.2
Income from continuing operations
EBIT $180.8 $203.6 $160.6 $65.6
Income tax expense -$0.3 $23.3 $10.5 -$20.1
Interest expense $193 $234.9 $221 $201.8
Net income
Net income -$11.9 -$54.6 -$70.9 -$116.1
Income (for common shares) -$11.9 -$54.6 -$81.2 -$155.6
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$1 -$4.9 $18.9 -$24.9
Operating activities
Depreciation $39.9 $37.4 $33.3 $42.7
Business acquisitions & disposals -$31.2 -$5.3 -$2.8 -$40.7
Stock-based compensation $4.5 $4.4 $4.6 $4.2
Total cash flows from operations $62.6 $104.6 $52.1 $74.5
Investing activities
Capital expenditures -$19.8 -$19.2 -$7.7 -$16.3
Investments $0.3 -$0.8 -$38.8 -$9.6
Total cash flows from investing -$58.1 -$25.6 -$71.2 -$70.7
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$15.6 $17.2 -$5.1 -$1.3
Total cash flows from financing -$44.6 -$20.4 -$49 -$41.2
Effect of exchange rate
Change in cash and equivalents -$40.1 $58.6 -$68.1 -$37.4
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$11.9 -$54.6 -$70.9 -$116.1
Operating activities
Depreciation $153.3 $149.6 $137.9 $134.2
Business acquisitions & disposals -$80 -$146.4 -$285.8 -$104.6
Stock-based compensation $17.7 $18.4 $17.4 $13.2
Total cash flows from operations $293.8 $158.8 $87.1 $246.9
Investing activities
Capital expenditures -$63 -$67.7 -$51.6 $15.6
Investments -$48.9 -$82.3 $5.4
Total cash flows from investing -$225.6 -$307.9 -$331.7 -$88.4
Financing activities
Dividends paid
Sale and purchase of stock $857.7 $554.2
Net borrowings -$4.8 -$655.5 -$55.5 $204.6
Total cash flows from financing -$155.2 $42.1 $316.3 $66.7
Effect of exchange rate
Change in cash and equivalents -$87 -$107 $71.7 $225.2
Fundamentals
Market cap $3.78B
Enterprise value $6.60B
Shares outstanding 126.59M
Revenue $2.74B
EBITDA $334.10M
EBIT $180.80M
Net Income -$11.90M
Revenue Q/Q 4.00%
Revenue Y/Y 8.03%
P/E ratio -317.34
EV/Sales 2.41
EV/EBITDA 19.77
EV/EBIT 36.53
P/S ratio 1.38
P/B ratio 1.96
Book/Share 15.24
Cash/Share 1.55
EPS -$0.09
ROA -0.18%
ROE -0.60%
Debt/Equity 1.93
Net debt/EBITDA 10.91
Current ratio 1.71
Quick ratio 1.57